---------- Forwarded message ----------
From: PlusNews <[email protected]>
Date: Tue, Apr 17, 2012 at 2:09 PM
Subject: NEPAL: Treatment illiteracy puts HIV benchmarks in peril
To: Elisabeth Janaina <[email protected]>


NEPAL: Treatment illiteracy puts HIV benchmarks in peril

KATHMANDU, 17 April 2012 (PLUSNEWS) - Poor understanding of
antiretroviral therapy (ART) amongst health officials, clinicians and
patients in Nepal could undermine gains in the country's HIV/AIDS
prevention efforts and threaten future progress in lowering the number
of new infections.

"Treatment illiteracy is occurring at all levels, from patients who
have to keep up with their own treatment, to clinicians who administer
treatment, to government officials crafting policies," said Gokaran
Bhatt, coordinator of Nepal's Country Coordinating Mechanism, the
independent body tasked with coordinating all money granted to Nepal
by the Global Fund to Fight AIDS, Tuberculosis (TB) and Malaria. [
http://www.theglobalfund.org/en/ccm/ ]

Government figures for 2012 put HIV prevalence in the adult population
at below 0.3 percent, down from 0.45 percent in 2005.

According to Nepal's first National AIDS Response Progress report, [
http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/progressreports/2012countries/ce_NP_Narrative_Report.pdf
] an estimated 50,000 people are living with HIV, and four out of
every five new infections are attributed to sexual transmission. ART
was introduced in Nepal in 2004 and 6,483 people are currently
receiving antiretroviral (ARV) drugs.

"Given the poverty and geographical challenges in Nepal, we are doing
extremely well here," Sashi Sharma, head of the Internal Medicine Unit
at the Teaching Hospital in the capital, Kathmandu, told IRIN.

But many now argue those gains could evaporate if proper adherence to
treatment policies and regimens is not exercised.

Patient adherence

It is extremely important that patients always follow their ART
regimen. "In a resource-poor country like Nepal, adherence is our only
option to survive, and the baseline of adherence is treatment
literacy," said Rajhiv Khafle, founder of the National Association of
People Living with HIV Nepal (NAP+N). [ http://www.napn.org.np/ ]

Health workers stress that patients need a combination of counselling
and monitoring to help them understand that they must always take
their medicines at the same time each day, and that a dose should
never be skipped. "Before ART can start, patients have to go through a
full two-day counselling session," noted Madhab Raj Pant, an HIV
technical officer who worked in rural Doti District for two years.

To ensure that patients will visit the distribution centre, get
tested, and receive ongoing counselling, ART medicines are dispensed
on a monthly basis. Nepal currently reports a "lost cases" rate of 9
percent - patients who start on ART and then do not return for three
consecutive months.

A variety of reasons can cause patients not to adhere to their
regimen. In some areas, difficult terrain makes travelling to the
nearest ART distribution centre costly and time-consuming. Bishnu
Pokhrel*, who lives in a village in the Doti area, has to walk for a
whole day to reach the nearest ART distribution centre. Public
transportation is too expensive, and can also be unreliable due to
landslides and strikes, he said.

When travel is impossible, some patients turn to HIV-positive friends
to borrow doses of drugs. "Borrowing is not good practice. It
encourages irregular taking of medication and patients aren't medical
professionals, so they might take the incorrect dose or incorrect
pills," Pant explained.

Breaking away from ART can harm the positive health effects of
following a regular regimen. "We sometimes see a drop-off or a gap in
adherence after the first six or seven months," said Pant. "When
patients feel better, they sometimes think they are cured."

Clinician adherence

ARV treatment illiteracy on the part of clinicians can also cause
problems. Dilip Gurung, the executive director of a community support
group in the city of Pokhara, reports that he has sometimes seen
clinicians change ART regimens several times to try to get the patient
to feel better.

"Changing ART regimens can lead to fear among patients, confusion
about how to properly administer the new drugs, and drug resistance,"
Gurung said.

Public health officials agree. "It scares us if people are
administering combinations that are not part of the national
guidelines. If the patients on these drugs have problems or build
resistance, we can't help them - the national system can only help
people within its guidelines," said Hemant Ojha of the National Centre
for AIDS and STD (sexually transmitted diseases) Control (NCASC) [
http://www.ncasc.gov.np/ ]

Some outreach workers say drugs alone are not enough. "Clinicians
sometimes act as if ART is a solution alone," said Ekta Mahat, a
programme officer at NAP+N. "It's not - you need nutrition, a
realistic access plan based on the patient's life, education about
possible side effects, and discipline to take the medication at the
right time."

Policy adherence

According to the NCASC, Nepal has approximately 196 HIV testing and
counselling centres [
http://www.unaids.org/en/dataanalysis/monitoringcountryprogress/progressreports/2012countries/ce_BD_Narrative_Report[1].pdf
], as well as 35 ART distribution centres and sub-centres located
throughout the country. [
http://www.ncasc.gov.np/uploaded/SDP/ART_Sites_in_Nepal_2010.pdf ] All
ART drugs are distributed free of charge.

But "availability is not necessarily accessibility", Mahat said.
Policies that neglect the comprehensive nutritional, financial,
educational, and pharmaceutical needs of people living with HIV/AIDS
amount to treatment illiteracy at the policy level.

Moreover, government guidelines and the strategies of some HIV NGOs do
not always take the same approach. "When we get a call from a patient
whose ART isn't working, we mobilize to get that person help," said
Khafle of NAP+N. "It's not a public health approach, it's a
humanitarian approach."

Observers fear the positive results from national HIV efforts could be
diluted if tensions over the administration of HIV programmes
continue, and adherence issues hamper implementation.

"Nepal has done extremely well in the last decade," said Marlyn Elena
Filio-Borromeo, UNAIDS country coordinator, "but these gains are
fragile."

*not his real name

kk/ds/he


[END]

This report online: http://www.plusnews.org/report.aspx?reportID=95303



Follow us on Twitter! http://twitter.com/plusnews

© IRIN. All rights reserved. HIV/AIDS news and analysis:
http://www.plusnews.org/

[This item comes to you from PlusNews, part of IRIN, the humanitarian
news and analysis service of the UN Office for the Coordination of
Humanitarian Affairs. The opinions expressed do not necessarily
reflect those of the United Nations or its Member States. Reposting or
reproduction, with attribution, for non-commercial purposes is
permitted. Terms and conditions: http://www.irinnews.org/copyright

Principal IRIN/PlusNews donors: UAE, Canada, Germany, Ireland,
Netherlands, Norway, Sweden, Switzerland, UK and the IHC. More
information: http://www.irinnews.org/donors

This mail is from an automatic address. Contact PlusNews at:
[email protected]. Revise/stop your subscription:
http://bit.ly/9nCoUP ]

Subscribed email: [email protected]

-- 
You received this message because you are subscribed to the Google Groups 
"South Sudan Info - The Kob" group.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to 
[email protected].
For more options, visit this group at 
http://groups.google.com/group/SouthSudanKob?hl=en.

Reply via email to